Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Lymphoma, T-Cell, Peripheral × Immunotherapy, Adoptive × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Nasopharyngeal Carcinoma 2 Lymphoma, Large B-Cell, Diffuse 2 Pyloric Stenosis, Hypertrophic 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Multiple Myeloma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myeloid, Acute 1 Colorectal Neoplasms 1

Interventions

Immunotherapy, Adoptive 1 CF regimen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05979792 2023-08-21

Clinical Study of CD7 CAR-T Cell Injection in the Treatment of Patients With Relapsed or Refractory CD7-positive Peripheral T Cell Lymphoma

Ruijin Hospital

Phase EARLY_PHASE1 Unknown

Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon ⚡